FDA.reportPublic FDA data

tacrolimus 0.2 MG Granules for Oral Suspension [Prograf]

RxCUI
2052609
RxNorm name
tacrolimus 0.2 MG Granules for Oral Suspension [Prograf]
Display name
tacrolimus 0.2 MG Granules for Oral Suspension [Prograf]
Full name
tacrolimus 0.2 MG Granules for Oral Suspension [Prograf]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PrografTACROLIMUSAstellas Pharma US, Inc.7f667de1-9dfa-4bd6-8ba0-15ee2d78873b2023-08-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2052609

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7f667de1-9dfa-4bd6-8ba0-15ee2d78873bPrograf 0.2 MG Granules for Oral Suspension [PSN] · tacrolimus 0.2 MG Granules for Oral Suspension [Prograf] [SBD] · Prograf 0.2 MG Granules for Oral Suspension [SY]330These highlights do not include all the information needed to use PROGRAF ® safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, for oral use PROGRAF (tacrolimus) injection, for intravenous use PROGRAF Granules (tacrolimus for oral suspension) Initial U.S. Approval: 199420230825